Jeremy L. Stigall - May 13, 2022 Form 3 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
GM, Biologics & Drug Delivery
Signature
/s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Stock symbol
CLPT
Transactions as of
May 13, 2022
Transactions value $
$0
Form type
3
Date filed
5/19/2022, 09:59 PM
Next filing
Jun 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLPT Common Stock $25.7K May 13, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CLPT Stock Option (Right to Buy) May 13, 2022 Common Stock 5.88K $16.71 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 22,563 shares of restricted stock, 19,274 shares of which are unvested as of the date of this filing.
F2 The option agreement provides that the option becomes exercisable twenty percent (20%) on the first anniversary of the option's grant date with the remaining eighty percent (80%) becoming exercisable in two equal annual installments on the second and third anniversaries, respectively, of the option's grant date. The option was granted on August 20, 2021.

Remarks:

Power of Attorney is attached to this Form 3 as Exhibit 24.